NYMX News and Press, Nymox Pharmaceutical Corporation From 03/03/22

IRVINE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce today that it has submitted the Company’s New Drug Application (NDA) to the FDA for Fexapotide Triflutate to seek marketing approval...

Gainers: Inspirato (NASDAQ:ISPO) +48%. KAR Auction Services (NYSE:KAR) +40%. Farfetch (NYSE:FTCH) +39%. CarGurus (NASDAQ:CARG) +36%. Aerie (NASDAQ:AERI) +28%. IronNet (NYSE:IRNT) +26%. Nymox (NASDAQ:NYMX) +26%. Block (NYSE:SQ) +24%. Schrodinger (NASDAQ:SDGR) +21%. Paramount Group (NYSE:PGRE) ...

HASBROUCK HEIGHTS, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it has completed all the Company’s required tasks in preparation for its planned upcoming regulatory submission fo...

Nymox Pharmaceutical (NASDAQ:NYMX) has filed for a $25M mixed shelf offering. The filing does not necessarily indicate that a sale has begun, or will occur in the future. The offering is for common shares and debt securities. Nymox has been hit by several setbacks this year for its lead candi...

HASBROUCK HEIGHTS, N.J., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to report today a one-month update to shareholders as a follow-up to the September communication. The Company reinforces that its completi...

HASBROUCK HEIGHTS, N.J., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide an update on the Company's progress with its BPH treatment product Fexapotide Triflutate. The Company announced today that al...

Are These Penny Stocks On Your List Right Now? In this article, we will take a look at 4 penny stocks with upcoming events very soon. How do we know this? One of the great things about certain industries is that companies will pre-announced key dates well in advance. Biotech companies a...

Gainers: NanoVibronix NAOV +44%, Nymox Pharmaceutical (NASDAQ:NYMX) +21%, Travere Therapeutics TVTX +20%, Enlivex Therapeutics ENLV +15%, Collegium Pharmaceutical COLL +11%. Losers: Sesen Bio SESN -35%, ESSA Pharma EPIX -32...

Shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) traded at a new 52-week low today of $1.29. So far today approximately 132,000 shares have been exchanged, as compared to an average 30-day volume of 580,000 shares. There is potential upside of 24.7% for shares of Nymox Pharmaceut...

Shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) traded at a new 52-week low today of $1.38. Approximately 132,000 shares have changed hands today, as compared to an average 30-day volume of 576,000 shares. Nymox Pharmaceutical Corp is a biopharmaceutical company. The firm and it...